Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.94 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.62 |
| ▸ | ESR1 | P03372 | 7/20 | 0.62 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.58 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Betanaphthol SCHEMBL14973607 | 1.00 | CYP1A2 (0.94) | CYP1A2ESR2ESR1HSD17B1HSD17B2 | |
| Betanaphthol SCHEMBL29658180 | 0.97 | CYP1A2 (1.00) | CYP1A2ESR2ESR1HSD17B1HSD17B2 | |
| Betanaphthol SCHEMBL28781 | 0.97 | CYP1A2 (1.00) | CYP1A2ESR2ESR1HSD17B1HSD17B2 | |
| Betanaphthol SCHEMBL239472 | 0.97 | CYP1A2 (1.00) | CYP1A2ESR2ESR1HSD17B1HSD17B2 | |
| Betanaphthol SCHEMBL11594695 | 0.97 | CYP1A2 (1.00) | CYP1A2ESR2ESR1HSD17B1HSD17B2 | |
| Betanaphthol SCHEMBL3592033 | 0.94 | CYP1A2 (0.94) | CYP1A2ESR2ESR1HSD17B1HSD17B2 | |
| Betanaphthol SCHEMBL7614330 | 0.94 | CYP1A2 (0.94) | CYP1A2ESR2ESR1HSD17B1HSD17B2 | |
| Betanaphthol SCHEMBL11678336 | 0.94 | CYP1A2 (0.94) | CYP1A2ESR2ESR1HSD17B1HSD17B2 | |
| Betanaphthol SCHEMBL1154815 | 0.94 | CYP1A2 (0.94) | CYP1A2ESR2ESR1HSD17B1HSD17B2 | |
| Betanaphthol SCHEMBL9116084 | 0.94 | CYP1A2 (0.94) | CYP1A2ESR2ESR1HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102382042-A | Anthracene derivant and organic electroluminescence element using same | JNC KK | 2012-03-21 | — | — | CN | disclosed |
| CN-1938321-B | Novel compound and organic electronic device using such compound | MITSUI CHEMICALS INC | 2010-05-05 | — | — | CN | disclosed |
| US-7598667-B2 | Arylamine compound and organic electroluminescence device containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2009-10-06 | — | — | US | disclosed |
| CN-1938321-A | Novel compound and organic electronic device using such compound | MITSUI CHEMICALS INC (JP) | 2007-03-28 | — | — | CN | disclosed |
| US-20070018569-A1 | Arylamine compound and organic electroluminescence device containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2007-01-25 | — | — | US | disclosed |
| EP-1623970-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2006-02-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070018569-A1 | Arylamine compound and organic electroluminescence device containing the same | TRPA1, LIN28A, LEF1 | CYP1A2 1227/4885ESR2 217/4885ESR1 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.